Ospel Johanna Maria, Rinkel Leon, Ganesh Aravind, Demchuk Andrew, Joshi Manish, Poppe Alexandre, McTaggart Ryan, Nogueira Raul, Menon Bijoy, Tymianski Michael, Hill Michael Douglas, Goyal Mayank
Departments of Diagnostic Imaging (J.M.O., M.J., M.D.H., M.G.), Foothills Medical Center, University of Calgary, AB, Canada.
Neurosciences (J.M.O., L.R., A.G., A.D., M.J., B.M., M.D.H., M.G.), Foothills Medical Center, University of Calgary, AB, Canada.
Stroke. 2024 May;55(5):1349-1358. doi: 10.1161/STROKEAHA.123.045825. Epub 2024 Mar 21.
To assess the association of qualitative and quantitative infarct characteristics and 3 cognitive outcome tests, namely the Montreal Cognitive Assessment (MOCA) for mild cognitive impairment, the Boston Naming Test for visual confrontation naming, and the Sunnybrook Neglect Assessment Procedure for neglect, in large vessel occlusion stroke.
Secondary observational cohort study using data from the randomized-controlled ESCAPE-NA1 trial (Safety and Efficacy of Nerinetide in Subjects Undergoing Endovascular Thrombectomy for Stroke), in which patients with large vessel occlusion undergoing endovascular treatment were randomized to receive either intravenous Nerinetide or placebo. MOCA, Sunnybrook Neglect Assessment Procedure, and 15-item Boston Naming Test were obtained at 90 days. Total infarct volume, gray matter, and white matter infarct volumes were manually measured on 24-hour follow-up imaging. Infarcts were also visually classified as either involving the gray matter only or both the gray and white matter and scattered versus territorial. Associations of infarct variables and cognitive outcomes were analyzed using multivariable ordinal or binary logistic regression models.
Of 1105 patients enrolled in ESCAPE-NA1, 1026 patients with visible infarcts on 24-hour follow-up imaging were included. MOCA and Sunnybrook Neglect Assessment Procedure were available for 706 (68.8%) patients and the 15-item Boston Naming Test was available for 682 (66.5%) patients. Total infarct volume was associated with worse MOCA scores (adjusted common odds ratio per 10 mL increase, 1.05 [95% CI, 1.04-1.06]). After adjusting for baseline variables and total infarct volume, mixed gray and white matter involvement (versus gray matter-only adjusted common odds ratio, 1.92 [95% CI, 1.37-2.69]), white matter infarct volume (adjusted common odds ratio per 10 mL increase 1.36 [95% CI, 1.18-1.58]) and territorial (versus scattered) infarct pattern (adjusted common odds ratio, 1.65 [95% CI, 1.15-2.38]) were associated with worse MOCA scores. Results for Sunnybrook Neglect Assessment Procedure and 15-item Boston Naming Test were similar, except for the territorial infarct pattern, which did not reach statistical significance in multivariable analysis.
Besides total infarct volume, infarcts that involve the white matter and that show a territorial distribution were associated with worse cognitive outcomes, even after adjusting for total infarct volume.
评估大面积脑梗死患者梗死灶的定性和定量特征与3种认知结局测试(即用于评估轻度认知障碍的蒙特利尔认知评估量表(MOCA)、用于视觉命名的波士顿命名测试以及用于评估偏侧忽视的桑尼布鲁克偏侧忽视评估程序)之间的关联。
采用随机对照的ESCAPE-NA1试验(神经保护剂治疗急性缺血性卒中血管内取栓术后患者的安全性和有效性研究)数据进行二次观察性队列研究,将接受血管内治疗的大面积脑梗死患者随机分为静脉注射神经保护剂组或安慰剂组。在90天时进行MOCA、桑尼布鲁克偏侧忽视评估程序和15项波士顿命名测试。在24小时随访影像上手动测量梗死灶总体积、灰质梗死灶体积和白质梗死灶体积。梗死灶还通过视觉分类为仅累及灰质或同时累及灰质和白质,以及散在性梗死或区域性梗死。使用多变量有序或二元逻辑回归模型分析梗死灶变量与认知结局之间的关联。
ESCAPE-NA1试验纳入的1105例患者中,1026例在24小时随访影像上有可见梗死灶。706例(68.8%)患者可进行MOCA和桑尼布鲁克偏侧忽视评估程序,682例(66.5%)患者可进行15项波士顿命名测试。梗死灶总体积增加与MOCA评分降低相关(每增加10 mL校正后的共同比值比为1.05 [95% CI,1.04 - 1.06])。在调整基线变量和梗死灶总体积后,灰质和白质混合受累(与仅累及灰质相比,校正后的共同比值比为1.92 [95% CI,1.37 - 2.69])、白质梗死灶体积(每增加10 mL校正后的共同比值比为1.36 [95% CI,1.18 - 1.58])以及区域性(与散在性相比)梗死灶模式(校正后的共同比值比为1.65 [95% CI,1.15 - 2.38])与MOCA评分降低相关。桑尼布鲁克偏侧忽视评估程序和15项波士顿命名测试的结果相似,但区域性梗死灶模式在多变量分析中未达到统计学意义。
除梗死灶总体积外,即使在调整梗死灶总体积后,累及白质和呈区域性分布的梗死灶与更差的认知结局相关。